Study Claims Ozempic Lowers Biological Age
Researchers reveal that GLP-1 medication Ozempic may reduce biological age, offering new hope in the fight against aging and related health issues.
GLP-1 medications have proven to be incredibly versatile, originally developed as a treatment for diabetes, and later used for treating obesity and promoting weight loss.
According to a 32-week, double-blind, placebo-controlled trial by TruDiagnostic, Ozempic may reduce the user’s biologic age by just over three years.
GLP-1 medications have been shown to be useful in treating various other conditions, with many more still being researched.
Author's summary: Ozempic reduces biological age.
More News
- Spot the Anglican Irony - THE OTHER CHEEK
- Phinia: Q3 Earnings Snapshot - WTOP News
- Grokipedia launches after brief crash, accused of copying Wikipedia content - Tech Digest
- Elon Musk’s Unveils Grokipedia - IT News Africa | Business Technology, Telecoms and Startup News
- Tungsten Mining advances Mt Mulgine project in Western Australia
- In Review: Big-Ass Sword by Andreas Butzbach
- Landmark New Report Shows Canadian Lobbyists Represent Major Polluters Alongside Environmental Groups
- African tax leaders meet in Uganda to tackle effective taxation of the wealthy - Institute of Development Studies
- Almonty Industries to acquire tungsten project in Montana, US
- All-new 2026 Proton Saga revealed in full at the 47th ASEAN Summit